Therapeutic method using T cell growth factor

Details Therapeutic method using T cell growth factor Therapeutic method using T cell growth factor

1986-10-31

1989-06-20

Tarcza, John Edward

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

530351, 935107, A61K 3702, A61K 3526, C07J 1506

Patent

active

048409340

ABSTRACT:
Therapeutic methods and compositions using TCGF from HSB-2-ERICR cells and its mutants are disclosed.

REFERENCES:
patent: 4623622 (1986-11-01), Anderson
Mule et al., Science 225, pp. 1487-1489 (1984).
Mule et al., Journal of Immunology 135(1), pp. 646-652 (1985).
Jama, Apr. 3, 1987, vol. 257, No. 13, pp. 1729-1731, "Letter" to the editor.
Lala and Parhar, Cancer Research, 48, pp. 1072-1079, Mar. 1, 1988.
Kawase et al., Cancer Research, vol. 48, pp. 1173-1179, Mar. 1, 1988.
Jeevan and Asherson, Infection and Immunity, Mar. 1988, pp. 660-664.
Lee et al., Journal of Biological Response Modifiers, pp. 7:32-42.
Rosenberg, Lotze and Mule, Annals of Internal Medicine, 1988, 108:853-864.
Molecular Immunology 17:535-537 (1980) Deweck, "Lymphokines, Monokines and Cytokines: An Increasingly Valuable Object for Studies in Molecular Immunology".
Human Lymphocyte DIfferentiation: Its Application to Cancer, (1978), Minowada, p. 337, "Markers of Human Leukaemia-Lymphoma Cell Lines Reflect . . . ".
Human Lymphocyte Differentiation: Its Application to Cancer, (1978), Seligmann et al., p. 133, "Human Lymphoproliferative Diseases as Models . . . ".
J. Exp. Medicine, 152: 1709-1719 (1980), Gills & Watson, "Biochemical and Biological Characterization of Lymphocyte Regulatory Molecules".
J. Immunology, 129: 1499-1505 (1982), Gootenberg et al., "A Biochemical Variant of Human T Cell Growth Factor Produced by a Cutaneous T Cell . . . ".
Federation Proc., 37: 2748-2753 (1978), Song et al., "Chemical Characterization of Products of Activated Lymphocytes".
Cancer Treatment Reviews, 7: 245-252 (1980), White & Klein, "Large-Scale Production of Human Lymphoblastoid Interferon".
J. Immunology, 117: 548-554 (1976), Yoshida et al., "Lymphokine-Like Factors Produced by Human Lympho Cell Lines with B or T Cell Surface Markers".
J. Immunology, 127: 1936 (1981), Stadler et al., "Relationship of Cell Cycle to Recovery of IL 2 Activity from Human Mononuclear Cells, Human . . . ".
Immunological Rev., 45: 163-193 (1979), Moretta et al., "Human T Cell Subpopulations in Normal and Pathologic Conditions".
Immunological Rev., 51: 35-59 (1980), Gronvik & Andersson, "The Role of T Cell Growth Stimulating Factors in T Cell Triggering".
J. Immunologicall Methods, 33: 337-350 (1980), Rosenberg et al., "In VItro Growth of Murine T Cells III Method for Separation of T Cell Growth . . . ".
Annals N.Y. Academy Sci., 332: 423-432 (1979), Smith et al., "T-Cell Growth Factor-Mediated T-Cell Proliferation".
J. Exp. Med., 151: 1551-1556 (1980), Smith et al., "The Functional Relationship of the Interleukins".
Science, 193: 1007-1008 (1979) or (1976), Morgan et al., "Selective in vitro Growth of T Lymphocytes from Normal Human Bone Marrows".
Annals N.Y. Academy Sci., 332: 423-432 (1979) Smith et al., "T-Cell Growth Factor Mediated T-Cell . . . ".
Immunological Rev. 51: 337-357 (1980), Smith, "T-Cell Growth Factor".
Immunological Communications, 10: 697-706 (1982), Anderson et al., "An Acute Lymphoblastic Leukemia Which Produces Human T Cell Growth Factor" .
In Vitro, 9: 303-310 (1974), Lazarus et al., "Divergent Properties of Two Human Lymphocytic Cell Lines Isolated From a Single Specimen of . . . ".
J. Exp. Med., 153: 1198-1214 (1981), Kappler et al., "Antigen-Inducible, H-2-Restricted . . . ".
Federation Proc., 39: 802 (1980), Farrer et al.
J. Immunol., 121: 1270, (1978), Alvarez et al., "Cytotoxic Activities of Normal Cultured Human T Cells".
J. Immunol., 20: 2027 (1978), Gillis et al., "T Cell Growth Factor: Parameters of Production and a Quantitative Microassay for Activity".
J. Immunol., 120: 1967 (1978), Shaw et al., "Partial Purification and Molelcular Characterization of a Lymphokine (Costimulator) Required For . . . ".
J. Immunol., 123: 2851 (1979), Mattes et al., "Identification and Separation of Thy-1 Positive Mouse Spleen Cells Active in Natural Cytotoxicity and . . . ".
J. Immunol., 114: 116 (1975), Lobo et al., "Identification of Two Populations of Immunoglobulin-Bearing Lymphocytes in Man".
Cancer Res., 28: 1121 (1968) Adams et al., "Direct Implantation and Serial Transplantation of Human Acute Lymphoblastic Leukemia in Hamsters, SB-2".
Exp. Cell Res., 62: 5 (1970), Adams et al., "The Question of Stemlines in Human Acute Leukemia".
J. Exp. Med., 152: 1709, Gillis et al.
J. Immunol., 129: 2586 (1982), Palacios et al., "Cloned Lines of Interleukin 2 Producer Human T Lymphocytes".
Immunol. Rev., 63: 73 (1982).
Proc. Natl. Acad. Sci. U.S.A., 77: 1588 (1980), Reinherz et al., " Discrete Stages of Human Intrathymic Differentiation: Analysis of Normal Thymocytes . . . ".
J. Immunol., 127: 2361-2365 (1981), Frank et al., "Biochemical and Biologic Characterization of Lymphocyte Regulatory Molecules".
J. Immunol., 128: 1122-1127 (1982), Mier et al., "The Purification and Properties of . . . ".
Genetic Engineering , pp. 2-59, R. Williamson (1981).
Molecular Cellular Biology, 2: 161-170 (1982), Okayama & Berg, "High-Efficiency Cloning of Full-Length cDNA".
Nucelic Acid Res., 9: 2989 (1981), Ash-Horowicz & Beck, "Rapid & Efficient Cosmid Cloning".
Nature, 294: 697-699 (1981), Paul et al., "Long-Term Growth and cloning of Non-Transformed Lymphocytes".
Annals N.Y. Acad. Sci., 332: 423-432 (1979), Smith et al., "T Cell Growth Factor-Mediated T-Cell Proliferation".
Molecular Immunology, 17: 579-589 (1980), Smith et al., "Functional and Molecular Characteristics of T-Cell Growth Factor".
J. Immunol., 127: 2483-2487 (1981) Dauphinee et al., "Interleukin 2 Deficiency is a Common Feature of Autoimmune Mice".
J. Immunol., 128: 2358-2361 (1982), Thoman et al., "Cell-Mediated Immunity in Aged Mice: an Underlying Lesion in IL 2 Synthesis".
Nature, 291: 335-338 (1981), Henney et al., "Interleukin-2 Augments Natural Killer Cell Activity".
Nature, 300: 31-34 (1982), Warner, "Effects of a Cloned Cell Line With NK Activity on Bone Marrow Transplants, Tumour Development and Metastasis in vivo".
Proc. Am. Ass. Cancer Res., 20: 93 (1979), Smith, "The Inhibition of in vivo Growth by Cytotoxic T-Cell".
J. Immunol., 130: 222-227 (1983), Hefeneider et al., "In vivo Interleukin 2 Administration Augments the Generation of Alloreactive Cytolytic T . . . ".
J. Immunol., 126: 1120-1125 (1981) Farrar et al., "Regulation of the Production of Immune Interferon and Cytotoxic Lymphocytes by Interleukin 2".
J. Immunol., 128: 2217-2219 (1982), Torres et al., "Interleukin 2 Regulates Immune Interferon (IFN) Production by Normal and Suppressor Cell . . . ".
J. Immunol., 127: 2381 (1981) Frank et al.
J. Immunol., 128: 1122 (1981) Mier et al., "The Purification and Properties of Human T Cell Growth Factor".
J. Immunol., 126: 1351 (1981), Caplan et al., "Properties of Sodium Dodecyl Sulfate-Denatured Interleukin 2".
Prog. Allergy, 26: 137-238 (1979) Kindred, "Nude Mice in Immunology".
Nature, 284: 278 (1980) Wanger et al., "T-Cell Derived Helper Factor Allows in vivo Induction of Cytotoxic T Cells in nu
u Mice".
Immunol. Rev., 51: 337 (1980) Smith, "T-Cell Growth Factor".

Affiliated with

Also associated with

Rating

Therapeutic method using T cell growth factor does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Therapeutic method using T cell growth factor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic method using T cell growth factor will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-525453